Patents by Inventor Sushant Kumar Shrivastava

Sushant Kumar Shrivastava has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11286241
    Abstract: This invention is directed to compositions and methods for treating cancer in a patient.
    Type: Grant
    Filed: September 9, 2019
    Date of Patent: March 29, 2022
    Assignee: GLAX LLC
    Inventors: Rakesh K Srivastava, Sharmila Shankar, Sushant Kumar Shrivastava, Prabhash Nath Tripathi, Pavan Srivastava
  • Patent number: 11208389
    Abstract: This invention is directed to compositions, methods and kits that can be used for reducing cell viability, inducing cell apoptosis, and inhibiting cell proliferation, such as for the treatment of cancer. The invention is also directed to compositions, methods and kits that can be used for treating inflammatory conditions, such as by modulating inflammatory cytokines.
    Type: Grant
    Filed: April 29, 2019
    Date of Patent: December 28, 2021
    Assignee: GLAX LLC
    Inventors: Rakesh K Srivastava, Sharmila Shankar, Sushant Kumar Shrivastava, Anupam G. Banerjee
  • Publication number: 20200087267
    Abstract: This invention is directed to compositions and methods for treating cancer in a patient.
    Type: Application
    Filed: September 9, 2019
    Publication date: March 19, 2020
    Applicant: GLAX LLC
    Inventors: Rakesh K Srivastava, Sharmila Shankar, Sushant Kumar Shrivastava, Prabhash Nath Tripathi, Pavan Srivastava
  • Publication number: 20190336486
    Abstract: This invention is directed to methods for treating cancer and metabolic syndrome.
    Type: Application
    Filed: April 30, 2019
    Publication date: November 7, 2019
    Applicant: GLAX LLC
    Inventors: Rakesh K Srivastava, Sharmila Shankar, Sushant Kumar Shrivastava, Pavan Srivastava, Piyoosh Sharma, Prabhash Nath Tripathi
  • Publication number: 20190330165
    Abstract: This invention is directed to compositions, methods and kits that can be used for reducing cell viability, inducing cell apoptosis, and inhibiting cell proliferation, such as for the treatment of cancer. The invention is also directed to compositions, methods and kits that can be used for treating inflammatory conditions, such as by modulating inflammatory cytokines.
    Type: Application
    Filed: April 29, 2019
    Publication date: October 31, 2019
    Applicant: GLAX LLC
    Inventors: Rakesh K Srivastava, Sharmila Shankar, Sushant Kumar Shrivastava, Anupam G. Banerjee